Cargando…
Is dopaminergic medication dose associated with self-reported bruxism in Parkinson’s disease? A cross-sectional, questionnaire-based study
OBJECTIVES: It is not clear whether dopaminergic medication influences bruxism behaviour in patients with Parkinson’s disease (PD). Therefore, the aims are to investigate (i) the prevalence of possible (i.e., self-reported) bruxism (sleep and awake) in PD patients, and (ii) whether the use of dopami...
Autores principales: | Verhoeff, M. C., Koutris, M., van Selms, M. K. A., Brandwijk, A. N., Heres, M. S., Berendse, H. W., van Dijk, K. D., Lobbezoo, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060196/ https://www.ncbi.nlm.nih.gov/pubmed/32918624 http://dx.doi.org/10.1007/s00784-020-03566-0 |
Ejemplares similares
-
Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study
por: Verhoeff, Merel Charlotte, et al.
Publicado: (2022) -
Clinicians’ view on the management of oral health in Parkinson’s disease patients: a qualitative study
por: Verhoeff, Merel C., et al.
Publicado: (2023) -
Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review
por: Verhoeff, Merel C., et al.
Publicado: (2022) -
Oral health‐related quality of life in patients with Parkinson’s disease
por: Verhoeff, Merel C., et al.
Publicado: (2022) -
Association between polysomnographic parameters of sleep bruxism and attrition‐type tooth wear
por: Kapagiannidou, Despoina, et al.
Publicado: (2021)